Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Controlled, Double-blind Study to Investigate the Effects of a New Infant Formula on Growth, Safety, and Tolerance in Healthy Term Chinese Infants

NCT03520764 is registered in ClinicalTrials.gov with Danone Nutricia as lead sponsor.

NCT NCT03520764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03520764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Controlled, Double-blind Study to Investigate the Effects of a New Infant Formula on Growth, Safety, and Tolerance in Healthy Term Chinese Infants
Lead sponsor
Danone Nutricia
Phase
Not applicable
Overall status
Completed
Start date
April 3, 2018
Completion date
November 9, 2020
Enrollment
284 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

healthy infants